Skip to Content
Merck
  • Enabling large-scale genome editing at repetitive elements by reducing DNA nicking.

Enabling large-scale genome editing at repetitive elements by reducing DNA nicking.

Nucleic acids research (2020-04-22)
Cory J Smith, Oscar Castanon, Khaled Said, Verena Volf, Parastoo Khoshakhlagh, Amanda Hornick, Raphael Ferreira, Chun-Ting Wu, Marc Güell, Shilpa Garg, Alex H M Ng, Hannu Myllykallio, George M Church
ABSTRACT

To extend the frontier of genome editing and enable editing of repetitive elements of mammalian genomes, we made use of a set of dead-Cas9 base editor (dBE) variants that allow editing at tens of thousands of loci per cell by overcoming the cell death associated with DNA double-strand breaks and single-strand breaks. We used a set of gRNAs targeting repetitive elements-ranging in target copy number from about 32 to 161 000 per cell. dBEs enabled survival after large-scale base editing, allowing targeted mutations at up to ∼13 200 and ∼12 200 loci in 293T and human induced pluripotent stem cells (hiPSCs), respectively, three orders of magnitude greater than previously recorded. These dBEs can overcome current on-target mutation and toxicity barriers that prevent cell survival after large-scale genome engineering.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pifithrin-α, ≥95% (HPLC), powder
Sigma-Aldrich
Y-27632, InSolution, ≥95%, reversible, inhibitor of Rho kinases